A meta-analysis confirms that neoadjuvant chemoimmunotherapy improves survival outcomes in most patients with resectable NSCLC, except for overall survival in patients with baseline PD-L1 below 1%.
Metformin, a staple of glucose management for decades, is now being studied for use in a wide range of diseases from carotid atherosclerosis to vitiligo.
During radiotherapy for non–small cell lung cancer, an incidental dose of radiation to the pulmonary veins may trigger atrial fibrillation, a study has found.
The European Medicines Agency granted marketing authorization for tislelizumab and retifanlimab for the treatment of non–small cell lung cancer and Merkel cell carcinoma, respectively.
People with intellectual or developmental disabilities may be 2.57 times more likely to die of colorectal cancer than those without these disabilities.